Ailís Fagan

1.4k total citations
23 papers, 872 citations indexed

About

Ailís Fagan is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Ailís Fagan has authored 23 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Genetics. Recurrent topics in Ailís Fagan's work include Estrogen and related hormone effects (5 papers), HER2/EGFR in Cancer Research (3 papers) and Gene expression and cancer classification (3 papers). Ailís Fagan is often cited by papers focused on Estrogen and related hormone effects (5 papers), HER2/EGFR in Cancer Research (3 papers) and Gene expression and cancer classification (3 papers). Ailís Fagan collaborates with scholars based in Ireland, United States and United Kingdom. Ailís Fagan's co-authors include Desmond G. Higgins, Aedín C. Culhane, Claude Gaillardin, Geraldine Butler, Cornelia Kurischko, Kenneth H. Wolfe, Claire Kenny, Jean‐Louis Sébédio, Marianne C. Walsh and Lorraine Brennan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ailís Fagan

22 papers receiving 862 citations

Peers

Countries citing papers authored by Ailís Fagan

Since Specialization

Citations

This map shows the geographic impact of Ailís Fagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ailís Fagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ailís Fagan more than expected).

Fields of papers citing papers by Ailís Fagan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ailís Fagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ailís Fagan. The network helps show where Ailís Fagan may publish in the future.

Co-authorship network of co-authors of Ailís Fagan

This figure shows the co-authorship network connecting the top 25 collaborators of Ailís Fagan. A scholar is included among the top collaborators of Ailís Fagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ailís Fagan. Ailís Fagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Electronic patient-reported outcomes, fever management, and symptom prediction among patients with BRAF V600 mutant stage III–IV melanoma: The Kaiku Health platform 2024 ·SHILAP Revista de lepidopterología ·Peter Mohr, Paolo A. Ascierto, Alfredo Addeo, Maria Grazia Vitale, Paola Queirolo, Christian U. Blank, Jussi Ekström, (unknown), Vesa Kataja, (unknown), (unknown), (unknown), Ailís Fagan, (unknown), Rubén Marques, J. Lijnsvelt	1
2	Recurrent heart failure hospitalizations increase the risk of mortality in heart failure patients with atrial fibrillation and type 2 diabetes mellitus in the United Kingdom: a retrospective analysis of Clinical Practice Research Datalink database 2022 ·BMC Cardiovascular Disorders ·Raquel Lahoz, Ailís Fagan, (unknown), Clare Proudfoot, Stefano Corda, Rachel Studer	3
3	Recurrent Heart Failure Hospitalizations are Associated with Increased Cardiovascular Mortality in Patients with Heart Failure in Clinical Practice Research Datalink 2020 ·ESC Heart Failure ·Raquel Lahoz, Ailís Fagan, (unknown), Clare Proudfoot, Stefano Corda, Rachel Studer	34
4	Epigenome-wide SRC-1–Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast Cancer 2018 ·Clinical Cancer Research ·(unknown), Damir Varešlija, Sara Charmsaz, Ailís Fagan, (unknown), Nicola Cosgrove, Sinéad Cocchiglia, (unknown), Lance Hudson, Sudipto Das, Darran P. O’Connor, Philip J. O’Halloran, Andrew H. Sims, Arnold D. Hill, Leonie S. Young	17
5	Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer 2018 ·Oncogene ·(unknown), Sara Charmsaz, Damir Varešlija, Ailís Fagan, Nicola Cosgrove, Sinéad Cocchiglia, (unknown), (unknown), Fiona T. Bane, Lance Hudson, Arnold D. Hill, Jason S. Carroll, Aisling M. Redmond, Leonie S. Young	24
6	Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors 2016 ·Clinical Cancer Research ·Damir Varešlija, Jean McBryan, Ailís Fagan, Aisling M. Redmond, Hao Yuan, Andrew H. Sims, Arran Turnbull, J. Michael Dixon, Peadar Ó Gaora, Lance Hudson, (unknown), Arnold D. Hill, Leonie S. Young	17
7	The clinical impact of early immunological responses in human HER2-positive breast cancers on responsiveness to trastuzumab-based therapy. 2016 ·Journal of Clinical Oncology ·Alex J. Eustace, Sinéad Toomey, Joanna Fay, (unknown), (unknown), Elaine W. Kay, Darran P. O’Connor, Ailís Fagan, Leonie S. Young, Norma O’Donovan, Janice M. Walshe, Arnold D. Hill, Esther M. John, Colm Power, Deirdre Duke, Niamh Hambly, William M. Gallagher, John Crown, Bryan T. Hennessy	1
8	Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy 2015 ·Clinical Cancer Research ·Jean McBryan, Ailís Fagan, Damian McCartan, Fiona T. Bane, Damir Varešlija, Sinéad Cocchiglia, Christopher Byrne, Jarlath Bolger, Marie McIlroy, Lance Hudson, Paul Tibbitts, Peadar Ó Gaora, Arnold D. Hill, Leonie S. Young	20
9	Downregulation of Umbilical Cord Blood Levels of miR-374a in Neonatal Hypoxic Ischemic Encephalopathy 2015 ·The Journal of Pediatrics ·(unknown), Brian H. Walsh, Gerard M. Moloney, Sue Grenham, Ailís Fagan, Gerard W. O’Keeffe, Gerard Clarke, John F. Cryan, Timothy G. Dinan, Geraldine B. Boylan, Deirdre M. Murray	54
10	Abstract P3-05-24: Adaptation to AI therapy in breast cancer can induce dynamic alterations in ER activity resulting in estrogen independent metastatic tumours 2015 ·Cancer Research ·Damir Varešlija, Jean McBryan, Ailís Fagan, Aisling M. Redmond, Hao Yuan, Arnold D. Hill, Leonie S. Young	0
11	Global Gene Repression by the Steroid Receptor Coactivator SRC-1 Promotes Oncogenesis 2014 ·Cancer Research ·Claire Walsh, Jarlath Bolger, Christopher M. Byrne, Sinéad Cocchiglia, Hao Yuan, Ailís Fagan, Li Qin, (unknown), Damian McCartan, Marie McIlroy, Peadar Ó Gaora, Jianming Xu, Arnold D. Hill, Leonie S. Young	27
12	Regulation of LPS Tolerance in Macrophages (48.2) 2012 ·The Journal of Immunology ·Christine O’Carroll, Ailís Fagan, Ruaidhrı́ J. Carmody	1
13	Global Characterization of the SRC-1 Transcriptome Identifies ADAM22 as an ER-Independent Mediator of Endocrine-Resistant Breast Cancer 2011 ·Cancer Research ·Damian McCartan, Jarlath Bolger, Ailís Fagan, Christopher M. Byrne, Hao Yuan, Li Qin, Marie McIlroy, Jianming Xu, Arnold D. Hill, Peadar Ó Gaora, Leonie S. Young	44
14	Chemostat‐based transcriptional analysis of growth rate change and BCL‐2 over‐expression in NS0 cells 2011 ·Biotechnology and Bioengineering ·(unknown), Ailís Fagan, Peadar Ó Gaora, Mohamed Al‐Rubeai	6
15	Altered Cytoplasmic-to-Nuclear Ratio of Survivin Is a Prognostic Indicator in Breast Cancer 2008 ·Clinical Cancer Research ·Donal J. Brennan, Elton Rexhepaj, Sallyann L. O’Brien, Elaine McSherry, Darran P. O’Connor, Ailís Fagan, Aedín C. Culhane, Desmond G. Higgins, Karin Jirström, Robert C. Millikan, Göran Landberg, Michael J. Duffy, Stephen M. Hewitt, William M. Gallagher	71
16	Influence of acute phytochemical intake on human urinary metabolomic profiles 2007 ·American Journal of Clinical Nutrition ·Marianne C. Walsh, Lorraine Brennan, Estelle Pujos‐Guillot, Jean‐Louis Sébédio, Augustin Scalbert, Ailís Fagan, Desmond G. Higgins, Michael J. Gibney	51
17	A multivariate analysis approach to the integration of proteomic and gene expression data 2007 ·PROTEOMICS ·Ailís Fagan, Aedín C. Culhane, Desmond G. Higgins	54
18	Influence of acute phytochemical intake on human urinary metabolomic profiles 2007 ·American Journal of Clinical Nutrition ·Marianne C. Walsh, Lorraine Brennan, Estelle Pujos‐Guillot, Jean‐Louis Sébédio, Augustin Scalbert, Ailís Fagan, Desmond G. Higgins, Michael J. Gibney	109
19	Application of DNA microarray technology in determining breast cancer prognosis and therapeutic response 2005 ·Expert Opinion on Biological Therapy ·Donal J. Brennan, Sallyann L. O’Brien, Ailís Fagan, Aedín C. Culhane, Desmond G. Higgins, Michael J. Duffy, William M. Gallagher	40
20	Evolution of the MAT locus and its Ho endonuclease in yeast species 2004 ·Proceedings of the National Academy of Sciences ·Geraldine Butler, Claire Kenny, Ailís Fagan, Cornelia Kurischko, Claude Gaillardin, Kenneth H. Wolfe	164

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact